0 (0%) | 03-29 00:43 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 23.41 | 1-year : | 27.35 |
Resists | First : | 20.04 | Second : | 23.41 |
Pivot price | 19.29 | |||
Supports | First : | 19.1 | Second : | 18.52 |
MAs | MA(5) : | 19.36 | MA(20) : | 19.31 |
MA(100) : | 18.78 | MA(250) : | 21.76 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 61.8 | D(3) : | 50.9 |
RSI | RSI(14): 57.9 | |||
52-week | High : | 27.1 | Low : | 13.31 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ARR ] has closed below upper band by 19.0%. Bollinger Bands are 26.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 19.84 - 19.94 | 19.94 - 20.02 |
Low: | 19.3 - 19.41 | 19.41 - 19.52 |
Close: | 19.59 - 19.77 | 19.77 - 19.94 |
Thu, 28 Mar 2024
GPNs 'put to one side' in place of ARRS staff - Nursing in Practice
Wed, 27 Mar 2024
'Trojan Horse' ARRS scheme 'replacing GPs', warns BMA sessional leader - Pulse
Tue, 19 Mar 2024
ARRIS International PLC (ARRS) Files 10-K for the Fiscal Year Ended on December 31, 2018 - AOL
Fri, 15 Mar 2024
ARRS announces recipients of continuing education grant - Health Imaging
Fri, 15 Mar 2024
ARRS names Clinician Educator Development program recipients - AuntMinnie
Wed, 13 Mar 2024
ARRS presents 2024 awards to 4 radiologists for groundbreaking research - Health Imaging
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 49 (M) |
Shares Float | 48 (M) |
Held by Insiders | 0.6 (%) |
Held by Institutions | 56.6 (%) |
Shares Short | 3,570 (K) |
Shares Short P.Month | 3,450 (K) |
EPS | -1.87 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 26.04 |
Profit Margin | 0 % |
Operating Margin | 89.8 % |
Return on Assets (ttm) | -0.7 % |
Return on Equity (ttm) | -5.7 % |
Qtrly Rev. Growth | 126 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | -0.5 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 57 % |
Operating Cash Flow | 133 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -10.63 |
PEG Ratio | -0.5 |
Price to Book value | 0.75 |
Price to Sales | -39.55 |
Price to Cash Flow | 7.25 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |